Evidence map›Paper›PMID 37224172›Full record

ArticleActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2023

Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma.

Chiara Bianchini, Matteo Caracciolo, Luca Urso, Andrea Ciorba, Anna Bonsembiante, Andrea Migliorelli, Virginia Corazzi, Ilaria Carandina, Naima Ortolan, Corrado Cittanti and 4 more

Open access · goldAbstract read
In one paragraph

Article in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Chiara Bianchini *ENT and Audiology Department, University Hospital of Ferrara, Ferrara, Italy.
Matteo Caracciolo *Translational Medicine Department, Ferrara University, Ferrara, Italy.
Luca UrsoTranslational Medicine Department, Ferrara University, Ferrara, Italy.
Andrea CiorbaENT and Audiology Department, University Hospital of Ferrara, Ferrara, Italy.
Anna BonsembianteENT and Audiology Department, University Hospital of Ferrara, Ferrara, Italy.
Andrea MigliorelliENT and Audiology Department, University Hospital of Ferrara, Ferrara, Italy.
Virginia CorazziENT and Audiology Department, University Hospital of Ferrara, Ferrara, Italy.
Ilaria CarandinaOncological Medical and Specialists Department, Oncology Unit, University Hospital of Ferrara, Ferrara, Italy.
Naima OrtolanTranslational Medicine Department, Ferrara University, Ferrara, Italy.
Corrado CittantiTranslational Medicine Department, Ferrara University, Ferrara, Italy.
Licia UccelliTranslational Medicine Department, Ferrara University, Ferrara, Italy.
Stefano PelucchiENT and Audiology Department, University Hospital of Ferrara, Ferrara, Italy.
Stefano PanareoNuclear Medicine Unit, Oncology and Haematology Department, University Hospital of Modena, Modena, Italy.
Mirco BartolomeiNuclear Medicine Unit, Oncological Medical and Specialists Department, University Hospital of Ferrara, Ferrara, Italy.
University of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The presence of cervical lymph node metastases (CLNM) at diagnosis is one of the most relevant negative prognostic factors in patients with head and neck squamous cell carcinoma (HNSCC). The aim of this study was to analyse 2-deoxy-2[ Methods: We retrospectively analysed patients who underwent FDG PET/CT for HNSCC staging between 2015-2020 at the University Hospital of Ferrara. All patients had cytological or histological confirmation of suspected cervical lymph nodes. Results: In total, 65 patients were enrolled (53 males, 12 females, median age 65.7 years). CLNM of patients with smoking habit had significantly higher SUVmax values than those of patients with previous smoking habit and non-smokers (p = 0.04). p16 positive HNSCC demonstrated a trend for higher SUVmax values on CLNM, in comparison to p16 negative tumours (p = 0.089). ROC curve analysis identified 5.8 as the best cut-off value of SUVmax for the detection of CLNM (AUC = 0.62, sensitivity 71.4% and specificity 72.7%). Conclusions: FDG PET/CT is a useful tool to evaluate CLNM in patients with HNSCC, particularly in those with smoking habit and p16 positive disease. A SUVmax cut-off of 5.8, combined with the use of conventional radiological investigations, may represent a useful tool in the identification of CLNM.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsAgedFemaleFluorodeoxyglucose F18HumansLymph NodesMalePositron-Emission TomographyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsRetrospective StudiesSensitivity and SpecificitySquamous Cell Carcinoma of Head and NeckFluorodeoxyglucose F18Radiopharmaceuticalslymph node metastasisPET/CTsquamous cell carcinomastandardized uptake value

Identifiers

PMID37224172
PMCPMC10366561
OpenAlexW4377970810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.